1. Home
  2. UNFI vs MESO Comparison

UNFI vs MESO Comparison

Compare UNFI & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Natural Foods Inc.

UNFI

United Natural Foods Inc.

HOLD

Current Price

$34.30

Market Cap

2.0B

ML Signal

HOLD

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$17.29

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNFI
MESO
Founded
1976
2004
Country
United States
Australia
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
UNFI
MESO
Price
$34.30
$17.29
Analyst Decision
Hold
Strong Buy
Analyst Count
8
2
Target Price
$37.13
$24.00
AVG Volume (30 Days)
896.5K
218.9K
Earning Date
03-10-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,753,000,000.00
$17,198,000.00
Revenue This Year
$2.45
$576.59
Revenue Next Year
$2.14
$41.15
P/E Ratio
N/A
N/A
Revenue Growth
1.45
191.39
52 Week Low
$20.78
$9.61
52 Week High
$43.29
$21.50

Technical Indicators

Market Signals
Indicator
UNFI
MESO
Relative Strength Index (RSI) 51.41 43.79
Support Level $32.06 $16.67
Resistance Level $35.25 $18.02
Average True Range (ATR) 1.20 0.68
MACD 0.21 -0.30
Stochastic Oscillator 70.53 13.04

Price Performance

Historical Comparison
UNFI
MESO

About UNFI United Natural Foods Inc.

United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.

Share on Social Networks: